1 mL of solution, and the rest depends on your dose. A 20 mg vial reconstituted to 20 mg/mL occupies 20 ÷ 20 = 1 mL. At a 1 mg weekly dose that is 20 weeks; at 2.4 mg weekly it is 8 weeks — and both of those assume the vial contains its label claim, which is the assumption a content assay exists to test. Subtract one draw's dead space per dose: a few microlitres on a fixed-needle syringe, up to a hundred on a luer one.
Write the units at every step, because units errors are the failure mode that catches everyone eventually.
Dead space quantified: a fixed-needle insulin syringe holds roughly 3 to 5 µL in the hub and needle after the plunger bottoms out. A luer-lock syringe with a detachable needle holds 35 to 100 µL depending on the hub design. At 5 mg/mL that is 15 to 25 µg lost per draw on the insulin syringe and 175 to 500 µg on the luer-lock — which over ten draws is the difference between losing a rounding error and losing half a milligram.
Worked example, because the general form is easier to trust once you have seen it once. Take a 10 mg vial and add 2 mL of diluent: the concentration is 10 ÷ 2 = 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL. On a U-100 syringe, where 1 unit = 0.01 mL, that is 0.1 ÷ 0.01 = 10 units. Change the diluent to 1 mL and the same dose becomes 5 units — same dose, half the resolution.
Published data on syringe dead space quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more for conventional detachable-needle syringes.
I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.
If in doubt, use more diluent and accept the shorter usable window.
4Would this be different for a peptide that foams? Mine does and I have never known why. – ravenna_pace 9 months ago 5I have seen exactly this failure mode twice and both times it was the diluent volume. – Dr_Elias_Weiss 11 days ago add a comment